There is no known AAA treatment prior to surgical intervention, which is only indicated for those with larger diameter (>5.5cm), late stage aneurysmal disease. 50% of patients with moderate sized (4-5.5cm) AAAs will progress and need surgery or endotherapy to avoid rupture. Vatrix is excited to announce the development of the only non-surgical intervention to halt the progress of AAA.
Dutch researchers say a half-glass of wine per day might help you live longer.
Source: Associated Newspapers Ltd | Daily Mail
Aneurysms are vascular disease processes that significantly weaken the arterial wall, resulting in gradual expansion until rupture occurs. In the case of rupture, the result is fatal approximately 90% of the time. Abdominal aortic aneurysms (AAAs) are the most prevalent type, ranking as the 13th leading cause of death in the United States. An estimated 1 million people in the US have an undetected aneurysm.
Clinical treatment of aneurysmal disease presents challenges. In a recent article Dr. B. Timothy Baxter, University of Nebraska Medical Center, states these "major clinical challenges in AAA disease include the absence of diagnostic biomarkers and effective nonsurgical therapies to prevent progression of early-stage disease".